1Hallenbeck JM, Dutka AJ. Background review and current concepts of reperfusion injury. Arch Neurol, 1990,47:1245.
2Suzuki J, et al. Chemiluminescence in hypoxic brain. Stroke,1988,19.65.
3Heystad L, Berg J, Lmagmoen IA. Failure of allopuriuol to protect against cerebral injury when given after the start of hytmxia. Acra Neurol Scand, 1991,83 : 286.
4McCord JM. Oxygen - derived free radicals in postisebemic tissue injury. N Engl J Med. 1985,312:159.
5Clark WM, Madden KP, Rolblein R, et al. Reduction of central nervous system ischemic injury in rabbits using leukcyte adhesion antibody treatment. Stroke, 1991,22 : 877.
6Wang PY, Kao CH, Mni MY, et al. Leukocyte infiltration in acute hemaispheric is chemaic stroke. Stroke, 1993,24: 236.
7Fisher M, Lesine PH,Cohen RA. A 21 - aminosteroid reduces hydrogen peroxide generation by and chemiluminesecence of stimulated human leukocytes. Stroke, 1990,21 : 1435.
8Chan PH. Brain injury edema and vascular permeability changes induced by oxygen - derived free radicals. Neurology,1984,34:315.
9Bozzo I, Famozzi LM, Bastianello S. Early collateral blood supply and late parenchymal brain damage in patient with middle cerebral artery occlusion. Stroke, 1989,20 : 735.
10Allcock JM. Occlusion of the middle cerebral artery:serial angiography as a guide to conservation therapy. J Neurosurg,1967,27:353.
8Pullicino P,NelsonRF,Kenall BE,et al.Small deep infarcts diagnosed on computed tomography[J].Neurology,1980,30(10):1090-1096.
9Tang M,Cyrus T,Yao Y,et al.Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2α-III:evidence from apolipoprotein E-and LDL receptor-deficient mice.Circulation,2005,112(18):2867-2874.
10Scholz H,Aukrust P,Damas JK,et al.8-isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages,resulting in long-lived foam cells[J].Eur J Clin Invest,2004,34(7):451-458.
